The α2δ-1-NMDA Receptor Complex Is Critically Involved in Neuropathic Pain Development and Gabapentin Therapeutic Actions

Cell Reports
Jinjun ChenHui-Lin Pan

Abstract

α2δ-1, commonly known as a voltage-activated Ca2+ channel subunit, is a binding site of gabapentinoids used to treat neuropathic pain and epilepsy. However, it is unclear how α2δ-1 contributes to neuropathic pain and gabapentinoid actions. Here, we show that Cacna2d1 overexpression potentiates presynaptic and postsynaptic NMDAR activity of spinal dorsal horn neurons to cause pain hypersensitivity. Conversely, Cacna2d1 knockdown or ablation normalizes synaptic NMDAR activity increased by nerve injury. α2δ-1 forms a heteromeric complex with NMDARs in rodent and human spinal cords. The α2δ-1-NMDAR interaction predominantly occurs through the C terminus of α2δ-1 and promotes surface trafficking and synaptic targeting of NMDARs. Gabapentin or an α2δ-1 C terminus-interfering peptide normalizes NMDAR synaptic targeting and activity increased by nerve injury. Thus, α2δ-1 is an NMDAR-interacting protein that increases NMDAR synaptic delivery in neuropathic pain. Gabapentinoids reduce neuropathic pain by inhibiting forward trafficking of α2δ-1-NMDAR complexes.

Citations

Feb 23, 2019·Cellular and Molecular Life Sciences : CMLS·Meichun DengHui-Lin Pan
Feb 2, 2019·Current Drug Targets·Amna KhanYeong Shik Kim
May 1, 2019·American Journal of Physiology. Endocrinology and Metabolism·A Sashi Papu JohnUtpal Sen
Jul 20, 2018·Molecular Pharmacology·Rían W Manville, Geoffrey W Abbott
Aug 11, 2018·American Journal of Physiology. Heart and Circulatory Physiology·Roger A DampneyHui-Lin Pan
Nov 14, 2019·Journal of Diabetes Investigation·Masayuki BabaShoichi Ohwada
Dec 4, 2019·The Journal of Clinical Investigation·Wenjing SunAndrea Tedeschi
Sep 23, 2020·Pharmaceutical Patent Analyst·Hermann Am Mucke
Jul 25, 2019·International Journal of Molecular Sciences·Arturo AndradeLaura Londrigan
Jul 2, 2020·Pflügers Archiv : European journal of physiology·Cornelia AblingerGerald J Obermair
Aug 2, 2020·Pain and Therapy·Heath McAnallyAlan D Kaye
Dec 20, 2018·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Shazli AzmiUazman Alam
Jun 27, 2019·Pharmaceuticals·Daria A BelinskaiaNatalia N Shestakova
Sep 5, 2019·The Journal of Pharmacology and Experimental Therapeutics·Shao-Rui ChenHui-Lin Pan
Jul 29, 2018·The Journal of Cell Biology·W Christopher RisherCagla Eroglu
Dec 7, 2018·Neuroscience Bulletin·Jing-Jing ZhouDe-Pei Li
Nov 30, 2018·Proceedings of the National Academy of Sciences of the United States of America·Manuela Nieto-RostroAnnette C Dolphin
Feb 10, 2020·Journal of Neural Transmission·Daniela C RosenbergerRolf-Detlef Treede
May 1, 2020·Frontiers in Cellular Neuroscience·Sascha R A AllesTerrance P Snutch
Jan 10, 2020·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Pablo Martínez San SegundoArtur Llobet
Mar 17, 2020·Cellular and Molecular Neurobiology·Mitra Sadat Tabatabaee, Frederic Menard
Oct 26, 2018·Stroke; a Journal of Cerebral Circulation·Yi LuoHui-Lin Pan
Jan 24, 2019·Frontiers in Pharmacology·Raquel Guerrero-AlbaBruno A Marichal-Cancino
Dec 13, 2018·Proceedings of the National Academy of Sciences of the United States of America·Jörg Striessnig
Jan 7, 2021·Anesthesiology·Po-Yi Paul Su, Zhonghui Guan
Jul 20, 2019·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·L HolperJ J Mann
Mar 3, 2020·Neuropharmacology·Graeme J Sills, Michael A Rogawski

❮ Previous
Next ❯

Methods Mentioned

BETA
LRET
sedation
Immunoprecipitation

Software Mentioned

ViraPower

Related Concepts

Related Feeds

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.